U.S.: FDA Denied Neuralink's Request for Human Trials

Reports emerged that in early 2022, the U.S. Food and Drug Administration denied an application from Elon Musk's Neuralink, a company focused on developing implantable brain-computer interfaces (BCIs), to begin human trials, according to Reuters on March 2....